PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-45.31%
Negative revenue growth while 8198.HK stands at 151.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-27.69%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-176.24%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-168.14%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-168.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-168.17%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 8198.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
234.80%
OCF growth of 234.80% while 8198.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
234.11%
FCF growth of 234.11% while 8198.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-80.43%
Negative 10Y revenue/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-81.30%
Negative 5Y CAGR while 8198.HK stands at 277.85%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-84.60%
Negative 3Y CAGR while 8198.HK stands at 466.73%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
546.56%
OCF/share CAGR of 546.56% while 8198.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
10.14%
Below 50% of 8198.HK's 231.37%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
411.16%
3Y OCF/share CAGR above 1.5x 8198.HK's 153.95%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-115.27%
Negative 10Y net income/share CAGR while 8198.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-132.26%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-244.87%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
9.09%
Equity/share CAGR of 9.09% while 8198.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-2.06%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-9.76%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-46.13%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-59.01%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.50%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.06%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-5.22%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.73%
SG&A declining or stable vs. 8198.HK's 26.54%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.